About Anaptysbio (ANAB)
AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more
- USD13.78
- USD14.32
- USD13.63
- USD41.31
- -37.60%
- 57M
- 388.50k
- 827.11k
- 443M
- 13.82
- -33.00%
Stock News
2 hours ago
These tips for investing in mutual funds and ETFs teach you new portfolio steps
MarketWatch
3 hours ago
American Express (AXP): 61% YTD Growth – What’s Fueling Its Continued Success?
Yahoo
3 hours ago
What’s Driving The Bank of New York Mellon’s (BK) 49% Surge in 2024?
Yahoo
4 hours ago
Meta gains for a third straight year depend on things the company can and can't control
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
